web analytics
Peter Angus, Pharm.D., Ph.D., Vice President of Pharmaceutical Research, Velesco Pharmaceutical Services

Peter Angus, Pharm.D., PhD - Vice President of Pharmaceutical Research

Scientific Leadership


Peter Angus, Pharm.D., Ph.D.


Peter Angus, Pharm.D., Ph.D., Director of Pharmaceutical Chemistry for Velesco Pharmaceutical Services

As the Vice President of Pharmaceutical Research for Velesco Pharmaceutical Services, Peter brings over a decade of experience working in the pharmaceutical industry. He has an extensive background in analytical method development and validation, cleaning verification and validation, project and laboratory management and management of analytical support for clinical supplies manufacturing for Phase I and Phase II clinical trials. 


His pharmaceutical industry experience extends across numerous types of drug product formulations including: standard immediate release capsule and tablet formulations; extended/delayed release formulations; softgel capsule formulations (encapsulations); tablets and capsules containing spray dried dispersions, spray layered dispersions, microbeads, hot-melt extrusions, spray-layered beads; IV solutions, and extemporaneously prepared solutions. Furthermore, Peter has expertise in early-stage topical, IV, and oral vehicle drug formulations for delivery of low solubility compounds.

Peter joined Velesco after working for in the Pharmaceutical Sciences Division of Pfizer Global Research & Development, and several years working for Pharmacia and G.D. Searle in Analytical Development. While at Pfizer, he served as the scientific lead and technical expert for a GMP product release laboratory. Peter was also responsible for managing a group of analytical scientists and numerous scientific and technical projects supporting development of compounds from discovery to Phase III.



He holds a Pharm.D. from the University of Michigan and a Ph.D. in Pharmaceutical Chemistry from the University of Kansas.

News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!

Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!

Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.

Roundtable: M&A trends in CDMO - Molecule to Market

New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!

1 new job postings! Careers

Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.

Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100